Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (1511)	11/29/1999 9:14:00 PM
From: Doug Bean	Read Replies (1) \| Respond to of 1837

Vestor: the 1.25 can only help me .. IF ,, it comes very soon , it will boost my calls in value. if it comes later.. i may already be back in. Either way i do not see it as boosting the stock for a long period. none of the "announcements" or " approvals have had a long lasting effect on DRMD. It pops up but pulls back fairly quickly. Earnings is what we need . Actual earnings . think of it this way DRMD was $6 just before the CENESTIN approval.. Its 7 13/16 now. We don't need more approvals ,, we need cash flow, big cash flow. I think we will get it, in fact i am sure we will. But not for a bit. CRDoug